Companies

See how salaries can vary from company to company

Stemline Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of oncology therapeutics in the United States and internationally. The company offers ELZONRIS, a targeted therapy directed to the interleukin-3 receptor (CD123) for patients with blastic plasmacytoid dendritic cell neoplasm in adults, and in pediatric patients two years and older. It also developing CD123 that is in Phase I/II clinical trials for the treatment of chronic myelomonocytic leukemia and myelofibrosis, as well as acute myeloid leukemia... view company details

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its proprietary pipeline includes therapeutic enzymes, gene therapies, and other products and product candidates affected by undesired immune responses. The company's lead product is SEL-212 that in Phase II clinical trials for the treatment of chronic refractory gout. It is also developing SEL-403, which is in Phase I clinical trials for the treatment of patients with malignant pleural or peritoneal mesothelioma.... view company details

Anixa Biosciences, Inc., a cancer-focused biotechnology company, develops both diagnostics and therapeutics to detect cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs, which genetically engineer a patient's own immune cells to fight cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in Octobe... view company details

Anatomy is a collaboration among fitness, sports science and nightlife veterans that embodies the future of fitness. We offer proprietary fitness programming, influenced by advanced research in strength conditioning and regeneration, designed for members to excel in all aspects of their lives. By partnering with leaders in age management, chiropractic care, IV nutritional therapy and beauty, we've created an intimate and integrated health and wellness community, where members can sweat, enhance and recover together, all under one roof. view company details

Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELx MP test to diagnose 12 new potential cancer sub-types in breast,... view company details

California College San Diego (CCSD) is a private college located in San Diego, California. The college is one of four educational institutions affiliated with the Salt Lake City-based Center for Excellence in Higher Education (CEHE). Associate's, bachelor's and master's programs in healthcare administration, medical specialties, respiratory therapy, business management and accounting, computer programming, computer networking, and computer science could be completed from CCSD. The college is accredited by Accrediting Commission of Career Schools and Colleges (ACCSC) which provides accreditatio... view company details

Comprehensive Behavior Supports is a leading New York and New Jersey provider for autism services. The organization provides in-home ABA Therapy which enables those diagnosed on the spectrum to reach their full potential. Our complementary intake concierge provides professional assistance to help you through the intake process. Board Certified Behavior Analysts (BCBAs) and ABA Therapists meticulously administer vital services with accuracy and compassion. Fine tuned efforts provide a higher quality of life. view company details

Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its lead product candidate is bempedoic acid/ezetimibe combination tablet, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. The company has a license and collaboration agreement with Daiichi ... view company details

Early Autism Services (EAS) provides individualized ABA therapy to children with autism and their families living across the United States, Canada and Australia. It is the mission of EAS to see each child that we work with reach their full potential in every area of development. EAS prides itself on having the expertise that comes from years of direct experience developing and implementing effective, high-quality ABA programming. Our programs draw on this expertise, while also relying on the ever growing body of research surrounding effective autism treatment. view company details

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201 a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee. Flexion Therapeutics, Inc. was founded... view company details

Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, voxelotor, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating voxelotor in SCD in a Phase III clinical trial in adult and adolescent patients with SCD. It is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase IIa clinical trial of adolescent and pediatric patients with SCD. Global Blood The... view company details

At Gateway Learning Group, we cultivate learning, language, behavior and social skills for individuals with Autism and other special needs. Using the principles of Applied Behavior Analysis (ABA) we design and implement an individualized therapy program for each child based on his or her particular needs and interests. Our therapists are experienced in a full range of the best treatments available including Verbal Behavior, Pivotal Response Treatments, Discrete Trial Training, and the Early Start Denver Model. To provide comprehensive support for our clients and their families, we also collabo... view company details

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was incorporated in 2013 and is he... view company details

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories... view company details

Find your success at IUP. Since its founding in 1875, Indiana University of Pennsylvania has progressed and evolved to match the changing needs of those it serves. Not only does IUP offer an abundance of undergraduate and master's programs, but it is the only university in the Pennsylvania State System of Higher Education to offer Doctor of Philosophy degrees. Degrees are offered from the broader, more traditional (philosophy, anthropology) to the career specific (safety sciences, respiratory therapy). Find out about our undergraduate majors: http://bit.ly/1hINzmJ Find out about our graduate p... view company details

InfuCare Rx is a leading data driven nationwide specialty infusion therapy provider focused on treating patients with chronic conditions who require comprehensive clinical management services. Today, many chronic conditions require specialized infusion therapies to help patients lead a healthy and productive lifestyle. InfuCare Rx provides a consistent, coordinated infusion experience for patients in the convenience of their home or alternate care setting. Our dedicated team of pharmacists, nurses and other trained professionals strive to provide optimal patient outcomes through cost effective... view company details

Krystal Biotech, Inc., a gene therapy company, develops and commercializes pharmaceutical products for patients suffering from dermatological diseases in the United States. The company's lead product candidate is KB103, which is in Phase II of a Phase I/II clinical study to treat dystrophic epidermolysis bullosa, a genetic disease. It is also involved in developing KB105 that is in preclinical studies for treating patients with deficient autosomal recessive congenital ichthyosis. The company was formerly known as Krystal Biotech, LLC and changed its name to Krystal Biotech, Inc. in March 2017.... view company details

DelMar Pharmaceuticals, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients who have failed to respond to modern therapy. Its product candidate includes VAL-083, a DNA-targeting agent, which is in Phase II clinical study for the treatment of glioblastoma multiforme (GBM), as well as other solid tumors, including ovarian cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China; and Duke University to evaluate VAL-083 as a fro... view company details

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp... view company details

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric ca... view company details